semaglutide and cardiovascular outcomes in obesity without diabetes journal club New Science Suggests Improves CV Beyond Weight Loss Cardiovascular Outcomes Associated with Semaglutide

If you find success with these, you might free up a GLP-1 prescription for someone who needs it more

Higher mortality in acute coronary syndrome patients without standard modifiable risk factors: results from a global meta-analysis of 1,285,722 patients

Other medications that cause drowsiness, such as beta-blockers to control blood pressure, are often used by people with type 2 diabetes

Vitamin K Dependent Antagonists Vitamin K antagonists (VKAs) are a class of anticoagulant medications used to prevent and treat blood clots

This means your body can produce it naturally, even if you do not consume it directly through food